Clinical studies recruiting near Beersheba

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Soroka Medical Center ( Site 0072) · Merck Sharp & Dohme LLC · NCT04165070 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Soroka Medical Center-Oncology ( Site 1704) · Merck Sharp & Dohme LLC · NCT06393374 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Be'er Sheva Mental Health Center · Bristol-Myers Squibb · NCT06929273 Transfer Effects of Stationary Bicycle Perturbation Training on Older Adults' Cycling Skills
NA · Physical Therapy department, faculty of health sciences, Ben · University of Erlangen-Nürnberg Medical School · NCT06453473 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Soroka Medical Center · Eli Lilly and Company · NCT07222332 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Soroka University Medical Centre · Gilead Sciences · NCT06051617 POST URS Chemotherapy Instillation
NA · Soroka University Medical Center · Carmel Medical Center · NCT06167057 Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Phase N/A · Soroka Medical Centre · Novartis Pharmaceuticals · NCT04174157 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Soroka University Medical Center /ID# 252711 · AbbVie · NCT04928846 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Soroka Medical Center ( Site 0606) · Merck Sharp & Dohme LLC · NCT06890884 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Institute of Gastroenterology and Liver Diseases - Soroka Un · Ipsen · NCT06016842 A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
NA · Soroka University Medical Center · Soroka University Medical Center · NCT06221254 Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction
NA · Soroka Medical Center · Brainsway · NCT07216872 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414 A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · Soroka University Medical Centre · Takeda · NCT05442567 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number: 3760003 · Sanofi · NCT07184931 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Phase 2 · Soroka University Medical Center · Rambam Health Care Campus · NCT05599347 A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · Soroka Medical Center · Janssen Research & Development, LLC · NCT07258511 A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Be'er Sheva Mental Health Center · Bristol-Myers Squibb · NCT07140913 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Children's Hospital at Soroka Medical Center · University Hospital Muenster · NCT04043494 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1213 · Anthos Therapeutics, Inc. · NCT05712200 Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · Soroka University Medical Center · Martin Schrappe · NCT03643276 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratum
Phase 3 · Soroka Medical Center · Pfizer · NCT05623020 A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomi
Phase 2 · Soroka University Medical Center · Karyopharm Therapeutics Inc · NCT04414475 A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · Clalit Health | Soroka Medical Center- Nephrology Department · Bayer · NCT05196035 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Soroka Medical Center · Janssen Research & Development, LLC · NCT05552222

Look up another city

Look up another condition